At InjectCo, every patient starts with a consultation where our team reviews your health history and builds a plan that fits your goals, medical needs, and budget
Not fat
Our team will ensure your treatment plan is safe and tailored to you
At 5 mg/mL it is 50 units
Safety data confirm that GLP-1RAs and TZP increase the risk of gastrointestinal adverse events (mostly mild-to-moderate), including nausea, diarrhea, and vomiting that are usually well-tolerated and resolved in a few weeks of treatment because of tachyphylaxis (especially with long-acting analogues and TZP)
In a 2-year carcinogenicity study in Sprague Dawley rats, subcutaneous doses of 0.0025, 0.01, 0.025 and 0.1 mg/kg/day were administered (below quantification, 0.4-, 1-, and 6-fold the exposure at the MRHD)